Navigation Links
New Drug Promising Against Rheumatoid Arthritis
Date:6/29/2009

Golimumab might help where similar drugs failed, research finds

MONDAY, June 29 (HealthDay News) -- The immunosuppressive drug golimumab shows promise in treating rheumatoid arthritis patients who don't respond to other drugs, according to a new study. Golimumab is from the family of drugs called tumor necrosis factor-a (TNF-a) inhibitors.

The new study included 461 patients in 10 countries who were randomly selected to receive either injections of placebo, 50 milligrams of golimumab or 100 milligrams of golimumab. The injections were given every four weeks for 24 weeks.

After 14 weeks, 35 percent of patients taking 50 milligrams of golimumab and 38 percent of those taking 100 milligrams of the drug achieved a 20 percent or higher improvement in American College of Rheumatology criteria for assessment of rheumatoid arthritis (ACR 20), compared with 18 percent of patients taking the placebo.

The study also found that among the 58 percent of patients who had discontinued a previous TNF-a inhibitor treatment because it wasn't effective, ACR 20 was achieved by 36 percent of patients taking 50 milligrams of golimumab, 43 percent of those taking 100 milligrams of golimumab and 18 percent of those in the placebo group.

After 24 weeks of treatment, serious adverse events were recorded in five percent of patients taking 50 milligrams of golimumab, four percent of those taking 100 milligrams of the drug and in 10 percent of patients on placebo.

"Golimumab reduces the signs and symptoms of active rheumatoid arthritis and improves physical function in patients who had previously received TNF-a inhibitors, which suggests that switching patients from one TNF-a inhibitor to golimumab is effective and generally well-tolerated," wrote Josef Smolen of the Medical University of Vienna and Hietzing Hospital in Vienna, Austria, and colleagues.

In a commentary, Dr. Yusuf Yazici of New York University Hospi
'/>"/>

Copyright©2009 ScoutNews,LLC.
All rights reserved  

Page: 1 2

Related medicine news :

1. Respiratory Rally a Promising Practice in the Fight Against Chronic Disease
2. Promising Therapy for Prostate Cancer
3. Promising biomarker and candidate tumor suppressor gene identified for colorectal cancer
4. AGH Joins Select Group of Medical Centers in Study of Promising New Technology for Treatment of Heart Failure
5. 17 of Americas Most Promising Scientists Selected as 2009 Pew Scholars in the Biomedical Sciences
6. CORRECTION: Viral Genetics Pursues Promising New Therapy for Lyme Disease With Grant from Time for Lyme, Inc.
7. Mayo Clinic Researchers Say Triple Drug Combination is Promising Option to Treat Metastatic HER2+ Breast Cancer
8. Triple drug combination is promising option to treat metastatic HER2+ breast cancer
9. Aleres Dr. Gordon Norman Highlights Challenges and Promising Solutions to U.S. Healthcare System to International Health Insurance Executives
10. New drug shows promising results for psoriatic arthritis
11. Will Obamas Stem Cell Announcement Doom Promising Adult Stem Cell Research?
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
New Drug Promising Against Rheumatoid Arthritis
(Date:7/24/2014)... July 25, 2014 Voted one of ... the global clients, BellasDress focuses on providing its new ... fashion information. Recently, the company has announced its new ... the new range is created according to the latest ... discounts, up to 68% off. , As a matter ...
(Date:7/24/2014)... 2014 The report, “Content Delivery ... market into various sub-segments with an in-depth analysis ... drivers and restraints for this market with insights ... market data tables and 36 figures spread through ... Networks (CDN) Market” at http://www.marketsandmarkets.com/Market-Reports/content-delivery-networks-cdn-market-657.html . ...
(Date:7/24/2014)... Just as fitness and health professionals ... own financial and marketing strength to be important as ... the next level by using the most powerful communication ... Broadcast, Call Tracking and SMS texting solutions . ... messages are quickly become integral in marketing and communication ...
(Date:7/24/2014)... its 2014 Power of A Award winners, including two ... , The ASA Global Humanitarian Outreach (GHO) program ... the top honors from ASAE. GHO was honored for ... on the global anesthesia crisis and supporting low income ... honored with a Power of A Silver Award for ...
(Date:7/24/2014)... appears to increase the risk for head and neck cancer ... with DM, but the risk of HNC in patients with ... cancer is the sixth most common type of cancer. It ... an estimated 650,000 new cancer cases and 350,000 cancer deaths ... Insurance Research Database to examine the risk of HNC in ...
Breaking Medicine News(10 mins):Health News:BellasDress Helps Brides Get High End Wedding Dresses for Their Romantic Weddings 2Health News:CDN Market by Delivery Technologies & Solutions Expected to Reach $12.16 Billion by 2019 - New Report by MarketsandMarkets 2Health News:CDN Market by Delivery Technologies & Solutions Expected to Reach $12.16 Billion by 2019 - New Report by MarketsandMarkets 3Health News:CDN Market by Delivery Technologies & Solutions Expected to Reach $12.16 Billion by 2019 - New Report by MarketsandMarkets 4Health News:Pump Up Your Gym’s Marketing Muscles with Mobile Marketing: CallFire's Health & Fitness Webinar Week – July 28th to August 1st 2Health News:Pump Up Your Gym’s Marketing Muscles with Mobile Marketing: CallFire's Health & Fitness Webinar Week – July 28th to August 1st 3
... sites nationwide, - Triples network bandwidth to more than 1 Gbps at ... ... solution, ROCHESTER, N.Y., March 18 Time Warner Telecom,Inc. (Nasdaq: ... businesses, today announced a multi-year, contract,to deploy an eight-site IP VPN solution ...
... PartsSource, the nation,s,leading supplier of replacement medical repair ... Team NEO award. Team NEO recognizes,the exceptional companies ... as the engines fueling the Cleveland area economy., ... what,s right about Northern Ohio,business," said President & ...
... Using data from the SCIAMACHY instrument aboard ESA,s Envisat ... regionally elevated atmospheric carbon dioxide the most important ... from manmade emissions. , More than 30 billion tonnes ... into the atmosphere annually by human activities, mainly through ...
... New U of T research holds promise for ... serve as a model for future therapies against the ... Stagljar, University of Toronto scientists have identified several compounds ... ExoS). One of these compounds, exosin, significantly inhibited infections ...
... March 18 On The Go,Healthcare, Inc. (OTC ... computer hardware, software and systems integrator,announced today that ... the Company has sold its Value Added Reseller ... (OTC Bulletin Board: FLIP). The,terms of the sale, ...
... or not relatives talk about the familys history of ... and testing for those at moderate risk of developing ... today at the American Society for Preventive Oncology meeting ... African Americans participate less often in genetic counseling and ...
Cached Medicine News:Health News:CooperVision Increases Network Performance While Reducing Costs With Time Warner Telecom's IP VPN 2Health News:CooperVision Increases Network Performance While Reducing Costs With Time Warner Telecom's IP VPN 3Health News:Envisat makes first ever observation of regionally elevated CO2 from manmade emissions 2Health News:Envisat makes first ever observation of regionally elevated CO2 from manmade emissions 3Health News:Research promising for cystic fibrosis 2Health News:On The Go Healthcare Sells VAR Business to Wireless and Internet Space Development Leader FTS Group 2Health News:On The Go Healthcare Sells VAR Business to Wireless and Internet Space Development Leader FTS Group 3Health News:On The Go Healthcare Sells VAR Business to Wireless and Internet Space Development Leader FTS Group 4Health News:Family communication impacts attitude about genetic counseling/testing for breast cancer 2
(Date:7/24/2014)... HILDEN , Deutschland, und ... , ... ermöglicht QIAGEN die Entwicklung von ... Genpanels, für Blutkrebs  Neuer Test ... Patienten mit Knochenmarkserkrankungen (myelodysplastischen Syndromen) einen günstigen ...
(Date:7/24/2014)... MOUNTAIN VIEW, Calif. , July 24, 2014 /PRNewswire/ ... that it will release its second quarter 2014 financial ... 31, 2014. In conjunction with the release, the ... community at 5:00 p.m. Eastern Time on ... results of the quarter and other business developments. ...
(Date:7/24/2014)... and MENLO PARK, Calif. , July 24, ... ("DelMar" "the company") announced today that the company,s board of ... December 31 to June 30. Accordingly, DelMar will file a ... Jeffrey Bacha , president and CEO of DelMar ... step in achieving our goal of obtaining a senior exchange ...
Breaking Medicine Technology:QIAGEN erweitert Pipeline für die personalisierte Medizin um vielversprechende genomische Biomarker zur Prognosebestimmung bei Blutkrebsbehandlungen 2QIAGEN erweitert Pipeline für die personalisierte Medizin um vielversprechende genomische Biomarker zur Prognosebestimmung bei Blutkrebsbehandlungen 3QIAGEN erweitert Pipeline für die personalisierte Medizin um vielversprechende genomische Biomarker zur Prognosebestimmung bei Blutkrebsbehandlungen 4QIAGEN erweitert Pipeline für die personalisierte Medizin um vielversprechende genomische Biomarker zur Prognosebestimmung bei Blutkrebsbehandlungen 5DelMar Pharmaceuticals Announces Change of Fiscal Year End and Provides Update on Glioblastoma Clinical Trial 2DelMar Pharmaceuticals Announces Change of Fiscal Year End and Provides Update on Glioblastoma Clinical Trial 3
... (Nasdaq: BMRN ) today announced that Jean-Jacques Bienaime, ... at the Wedbush Life Sciences Conference in New York on ... Interested parties may access a live audio webcast of the ... www.BMRN.com .  A replay of the call will be ...
... Merck,s Schering-Plough unit current and former pharmaceutical representatives ... opinion issued by a Federal Court in Connecticut. ... The law firms of Joseph, Herzfeld, Hester ... represent the plaintiffs in a Nationwide Collective Law Suit. ...
Cached Medicine Technology:BioMarin to Present at the Wedbush Life Sciences Conference 2UPDATE: Total Victory for Schering-Plough (Now Merck) Pharmaceutical Reps in National Suit for Overtime Pay 2
The Explorer 360 and 360 Jr. catheters have a rotational connector for ease of use during procedures....
... Webster is the source for a complete ... catheters for left-sided mapping - all with ... come to expect from the leader in ... sinus diagnostic catheters are specifically designed and ...
... Inquiry 5FR Soft HIS diagnostic ... a uniquely designed curve that ... in the HIS bundle. In ... designed to reduce the risk ...
Standard Deflectable Catheters...
Medicine Products: